(19)
(11)EP 3 359 128 A1

(12)

(43)Date of publication:
15.08.2018 Bulletin 2018/33

(21)Application number: 16787639.0

(22)Date of filing:  07.10.2016
(51)International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/22(2006.01)
A61K 47/26(2006.01)
A61K 9/107(2006.01)
A61K 31/00(2006.01)
A61K 47/14(2017.01)
A61K 47/24(2006.01)
A61K 47/28(2006.01)
A61K 9/127(2006.01)
(86)International application number:
PCT/US2016/056070
(87)International publication number:
WO 2017/062818 (13.04.2017 Gazette  2017/15)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30)Priority: 08.10.2015 US 201562239211 P

(71)Applicant: The Brigham and Women's Hospital, Inc.
Boston, MA 02115 (US)

(72)Inventors:
  • KARP, Jeffrey
    Cambridge, MA 02139 (US)
  • JOSHI, Nitin
    Cambridge, MA 02139 (US)
  • WIRADHARMA, Nikken
    Cambridge, MA 02139 (US)
  • SLAUGHTER, Kai, Vincent
    Cambridge, MA 02139 (US)

(74)Representative: Potter Clarkson LLP 
The Belgrave Centre Talbot Street
Nottingham NG1 5GG
Nottingham NG1 5GG (GB)

  


(54)STABILIZED ASSEMBLED NANOSTRUCTURES FOR DELIVERY OF ENCAPSULATED AGENTS